Sandra A. S. van Den Heuvel

Sandra A. S. van Den Heuvel

Auto-generated profile, based on publicly available information

Sandra A. S. van Den Heuvel

Department of Anesthesiology, Pain and Palliative Medicine, Radboudumc Nijmegen the Netherlands

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2015 in European journal of pain
Verified
Journal Article
Closed access
PDF file
SWS.E.I. van der Wal
S.E.I. van der Wal
SHS.A.S. van Den Heuvel
S.A.S. van Den Heuvel
SRS.A. Radema
S.A. Radema
BBB.F.M. van Berkum
B.F.M. van Berkum
MVM. Vaneker
M. Vaneker
KVK.C.P. Vissers
K.C.P. Vissers

28 March 2017 in Pain Research and Management
Verified
Journal Article
Open access
PDF file
SHSandra A. S. van Den Heuvel
Sandra A. S. van Den Heuvel
SWSelina E. I. van der Wal
Selina E. I. van der Wal
LSLotte A. Smedes
Lotte A. Smedes
SRSandra A. Radema
Sandra A. Radema
NANens van Alfen
Nens van Alfen
MSMonique A. H. Steegers
Monique A. H. Steegers
Background. Treatment of intractable pain due to chemotherapy induced peripheral neuropathy (CIPN) is a challenge. Intravenous (iv) lidocaine has shown to be a treatment option for neuropathic pain of different etiologies. Methods. Lidocaine (1.5 mg/kg in 10 minutes followed by 1.5 mg/kg/h over 5 hours) was administered in nine patients with CIPN, and analgesic effect was evaluated during infusion and after discharge. The immediate effect of lidocaine on pressure pain thresholds (PPT) and the extent of the stocking and glove distribution of sensory abnormalities (cold and pinprick) were assessed. Results. Lidocaine had a significant direct analgesic effect in 8 out of 9 patients (P=0.01) with a pain intensity difference of >30%. Pain reduction persisted in 5 patients for an average of 23 days. Lidocaine did not influence mean PPT, but there was a tendency that the extent of sensory abnormalities decreased after lidocaine. Conclusion. Iv lidocaine has direct analgesic effect in CIPN with a moderate long-term effect and seems to influence the area of cold and pinprick perception. Additional research is needed, using a control group and larger sample sizes to confirm these results.

1 November 2020 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
ANAnsbert S Ndebea
Ansbert S Ndebea
SHSandra As van Den Heuvel
Sandra As van Den Heuvel
RTRogers Temu
Rogers Temu
MKMwemezi M Kaino
Mwemezi M Kaino
RBRianne Van Boekel
Rianne Van Boekel
MSMonique Ah Steegers
Monique Ah Steegers
Background: In Africa, postoperative pain management is still a major problem with a prevalence of postoperative pain in up to 95.2% of the patients. There are little data on the prevalence and potential risk factors for postoperative pain in Tanzania. Therefore, we aimed to investigate these at Kilimanjaro Christian Medical Centre in Northern Tanzania. Our goal is to optimize pain management. Methods: A prospective cohort study was carried out from December 2016 to April 2017. Patients ≥ 18 years admitted for elective general or orthopedic surgery were included in the study. Demographic data were collected during a pre-operative visit, and pain was assessed with a numerical rating scale (NRS 0– 10) at 4, 24, 36 and 48 hours postoperatively. A NRS > 3 was considered as moderate to severe postoperative pain. Potential risk factors for postoperative pain were identified using univariate and multivariable binary logistic regression analyses. Results: A total of 281 patients were included in the study. The prevalence of postoperative pain was 61%, 73%, 67% and 58% at 4, 24, 36 and 48 hours after surgery, respectively. Pethidine was the most frequently prescribed analgesic for postoperative pain management (85.1%) in the first 24 hours postoperatively; only 1% received paracetamol or diclofenac, and 13% received tramadol. In the multivariable model, general anesthesia and intra-operative analgesia (OR = 3.70, 95% CI 1.70– 8.04) were significant risk factors for postoperative pain. Conclusion: Pain is still inadequately managed at Kilimanjaro Christian Medical Centre leading to a high prevalence (73% on the first day after surgery) of reported postoperative pain in this study. It reflects the need for adequate postoperative analgesia, especially in low- and middle-income countries. Further research identifying risk factors in larger cohorts can be performed if adequate analgesia is given.

28 August 2023 in Pain Practice
Verified
Journal Article
Open access
SHSandra A. S. Van Den Heuvel
Sandra A. S. Van Den Heuvel
SCSteven P. C. Cohen
Steven P. C. Cohen
JAJavier de Andrès Ares
Javier de Andrès Ares
KBKoen Van Boxem
Koen Van Boxem
JKJan Willem Kallewaard
Jan Willem Kallewaard
JZJan Van Zundert
Jan Van Zundert
Introduction: Pain originating from the lumbar facets can be defined as pain that arises from the innervated structures comprising the joint: the subchondral bone, synovium, synovial folds, and joint capsule. Reported prevalence rates range from 4.8% to over 50% among patients with mechanical low back pain, with diagnosis heavily dependent on the criteria employed. In well‐designed studies, the prevalence is generally between 10% and 20%, increasing with age.Methods: The literature on the diagnosis and treatment of lumbar facet joint pain was retrieved and summarized.Results: There are no pathognomic signs or symptoms of pain originating from the lumbar facet joints. The most common reported symptom is uni‐ or bilateral (in more advanced cases) axial low back pain, which often radiates into the upper legs in a non‐dermatomal distribution. Most patients report an aching type of pain exacerbated by activity, sometimes with morning stiffness. The diagnostic value of abnormal radiologic findings is poor owing to the low specificity. SPECT can accurately identify joint inflammation and has a predictive value for diagnostic lumbar facet injections. After “red flags” are ruled out, conservatives should be considered. In those unresponsive to conservative therapy with symptoms and physical examination suggesting lumbar facet joint pain, a diagnostic/prognostic medial branch block can be performed which remains the most reliable way to select patients for radiofrequency ablation.Conclusions: Well‐selected individuals with chronic low back originating from the facet joints may benefit from lumbar medial branch radiofrequency ablation.

1 January 2020 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
SHSandra As van Den Heuvel
Sandra As van Den Heuvel
SWSelina Ei van der Wal
Selina Ei van der Wal
Ewald BronkhorstEwald Bronkhorst
Ewald Bronkhorst
MWMichiel C Warlé
Michiel C Warlé
MRMay Ronday
May Ronday
MSMonique Ah Steegers
Monique Ah Steegers
Purpose: An imbalance in perioperative cytokine response may cause acute pain and postoperative complications. Anesthetic drugs modulate this cytokine response, but their role in non-major breast cancer surgery is unclear. In an exploratory study, we investigated whether intravenous lidocaine and dexamethasone could modulate the cytokine response into an anti-inflammatory direction. We also evaluated interrelationships between cytokine levels, pain scores and postoperative complications. Our goal is to develop multimodal analgesia regimens optimizing outcome after breast cancer surgery. Patients and Methods: Forty-eight patients undergoing a lumpectomy were randomly assigned to placebo or lidocaine (1.5 mg.kg(-1) followed by 2 mg.kg-1.hour(-1)) supplemented by dexamethasone zero, 4 or 8 mg, yielding six groups of eight patients. Interleukin (IL)-1 beta, IL-1Ra, IL-6, IL-10 levels and pain scores were measured at baseline and four hours postoperatively. We assessed postoperative complications occurring within 30 days. We noted persistent pain and infections as potential immune-related complications (PIRC). We used multiple regression to disentangle the effects of the individual study drugs (given by their partial regression coefficients (b)). Odds ratios (OR) estimated the link between pain scores and complications. Results: Dexamethasone 8 mg increased IL-10 (b=12.70 (95% CI=8.06-17.34), P<0.001). Dexamethasone 4 mg and 8 mg decreased the ratio IL-6/IL-10 (b=-2.60 (-3.93 to -1.26), P<0.001 and b=-3.59 (-5.04 to -2.13), P<0.001, respectively). We could not show modulatory effects of lidocaine on cytokines. High pain scores were linked to the occurrence of PIRC's (OR=2.028 (1.134-3.628), P=0.017). Cytokine levels were not related either to acute pain or PIRC. Conclusion: Dexamethasone modulated the perioperative cytokine response into an antiinflammatory direction. An overall lidocaine effect was not found. Patients with higher pain scores suffered from more 30-day PIRCs. Cytokine levels were not associated with pain or more postoperative complications, even not with PIRC. Larger studies in breast cancer surgery are needed to confirm these explorative results.

2 August 2017 in Trials
Verified
Journal Article
Open access
PDF file
RMRobbert C. Maatman
Robbert C. Maatman
MSMonique A. H. Steegers
Monique A. H. Steegers
OBOliver B. A. Boelens
Oliver B. A. Boelens
TLToine C. Lim
Toine C. Lim
HBHans J. van Den Berg
Hans J. van Den Berg
RRRudi M. H. Roumen
Rudi M. H. Roumen
Some patients with chronic abdominal pain suffer from an anterior cutaneous nerve entrapment syndrome (ACNES). This somewhat illusive syndrome is thought to be caused by the entrapment of end branches of the intercostal nerves residing in the abdominal wall. If ACNES is suspected, a local injection of an anesthetic agent may offer relief. If pain is recurrent following multiple-injection therapy, an anterior neurectomy entailing removal of the entrapped nerve endings may be considered. After 1 year, a 70% success rate has been reported. Research on minimally invasive alternative treatments is scarce. Pulsed radiofrequency (PRF) treatment is a relatively new treatment for chronic pain syndromes. An electromagnetic field is applied around the nerve in the hope of leading to pain relief. This randomized controlled trial compares the effect of PRF treatment and neurectomy in patients with ACNES. Adult ACNES patients having short-lived success following injections are randomized to PRF or neurectomy. At the 8-week follow-up visit, unsuccessful PRF patients are allowed to cross over to a neurectomy. Primary outcome is pain relief after either therapy. Secondary outcomes include patient satisfaction, quality of life, use of analgesics and unanticipated adverse events. The study is terminated 6 months after receiving the final procedure. Since academic literature on minimally invasive techniques is lacking, well-designed trials are needed to optimize results of treatment for ACNES. This is the first large, randomized controlled, proof-of-concept trial comparing two therapy techniques in ACNES patients. The first patient was included in October 2015. The expected trial deadline is December 2017. If effective, PRF may be incorporated into the ACNES treatment algorithm, thus minimizing the number of patients requiring surgery. Nederlands Trial Register (Dutch Trial Register), NTR5131 ( http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5131 ). Registered on 15 April 2015.